티스토리 뷰
Nintedanib Ethanesulfonate [B0084-434827][CAS no. 656247-18-6]_BOC Sciences - 코아사이언스
코피디 2023. 8. 18. 10:39Nintedanib Ethanesulfonate
=Intedanib Ethanesulfonate
Cat.# B0084-434827 / Size: 500mg
Nintedanib esylate is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β.
CAS no. 656247-18-6
Molecular Formula: C33H39N5O7S
Molecular Weight: 649.76
Related CAS: 656247-18-6 (esylate) 656247-17-5 (free base)
Appearance: Yellow solid powder
Synonyms: Methyl (3Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino) (phenyl)methylidene)-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ethanesulfonate; BIBF1120; BIBF 1120 BIBF-1120; Nintedanib esylate Nintedanib ethanesulfonate salt; Intedanib; Brand name OFEV Vargatef
IUPAC Name: ethanesulfonic acid;methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate
Application: the treatment of idiopathic pulmonary fibrosis
Melting Point: >233°C (dec.)
InChI Key: MMMVNAGRWOJNMW-FJBFXRHMSA-N
InChI: 1S/C31H33N5O4.C2H6O3S/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38;1-2-6(3,4)5/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38);2H2,1H3,(H,3,4,5)/b29-28-;
Canonical SMILES:
O=C(C1=CC(NC/2=O)=C(C=C1)C2=C(NC3=CC=C(N(C)C(CN4CCN(C)CC4)=O)C=C3)/C5=CC=CC=C5)OC.CCS(=O)(O)=O
* 본 상품은 오직 연구용으로만 사용 가능합니다. 인체 및 제품화에 사용하실 수 없습니다.
코아사이언스 coresciences BOC sciences USA Korea distributor 한국 대리점
'연구용 시약' 카테고리의 다른 글
- Total
- Today
- Yesterday
- 후나코시
- Sterlitech
- 건스터바이오텍
- 조직절편제작
- matrix-driven delivery pellet
- 미니멸균백
- 고수용성 콘드로이틴
- filter
- 조직염색절편제작
- Coresciences
- 조직절편
- allview PAGE buffer
- 오토클레이브백
- time release pellets
- 바이오헤저드백
- Funakoshi
- gradient gel
- 막필터
- OLED
- 면역화학분석
- material science
- 연속절편
- 바이오하자드백
- 코아사이언스
- 파라핀 블럭
- 파라핀 블록
- 콘드로이틴 황산 올리고당
- 형광염색
- solar cells
- OPV
일 | 월 | 화 | 수 | 목 | 금 | 토 |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 |